Transcription of Refeeding Syndrome Guideline
{{id}} {{{paragraph}}}
Example: quiz answers
Refeeding Syndrome Guideline
Refeeding Syndrome Refeeding Syndrome Guideline Author: Pamela Miller Responsible Lead Executive Director: Endorsing Body: Biochemistry Governance or Assurance Area Drug and Therapeutics Committee Committee Implementation Date: June 2020. Version Number: 3. Review Date: June 2023. Responsible Person Rebecca Ritchie Version Date: February 2017 Page 1 of 13. Refeeding Syndrome CONTENTS. i) Consultation and Distribution Record ii) Change Record 1. INTRODUCTION. 2. AIM, PURPOSE AND OUTCOMES. 3. SCOPE. Who is the Policy Intended to Benefit or Affect Who are the Stakeholders? 4. PRINCIPLE CONTENT. 5. ROLES AND RESPONSIBILITIES. 6. RESOURCE IMPLICATIONS. 7. COMMUNICATION PLAN. 8. QUALITY IMPROVEMENT MONITORING AND REVIEW. 9. EQUALITY AND DIVERSITY IMPACT ASSESSMENT. 10. REFERENCES. Version Date: February 2017 Page 2 of 13. Refeeding Syndrome CONSULTATION AND DISTRIBUTION RECORD. Contributing Author / Pamela Miller Surgical Pharmacist University Hospital Authors Wishaw Consultation Process / Dawn Stewart Deputy Head of pharmacy , University Stakeholders: Hospital Hairmyers Ian Godber Consultant Clinical Scientist, University Hospital Monklands Rebecca Ritchie Senior Pharmacist, University Hospital Wishaw Christine Brown Head of Dietetics, University Hospital Wishaw Sarah Connelly- Deputy Head of pharmacy , University Hospital Monklands Grace Davidson- Specialist Dietitian, University Hospital Wishaw Distribution.
type of TPN to be administered. For patient’s starting on TPN in the out of hours ... elements will be added to TPN daily by pharmacy. ... (4mmol per tablet) – 2 tablets 3 times a day for 2 weeks • Magnaspartate 243mg (10mmol per sachet) – 1 sachet 2-3 times daily for 3 days ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: